The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

9126–9150 of 18015

  • SevereFDA (Drugs)·D-0135-2019·2018-11-07

    Avella Recalls Phenylephrine Infusion Bags Due to Sterility Concerns

    Avella of Deer Valley is recalling 300 bags of Phenylephrine 30 mg in NS 250 mL due to a lack of assurance of sterility.

    Product
    Phenylephrine 30 mg added to NS 250 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0137-2019·2018-11-07

    Pharm D Solutions Recalls Arginine Injections Due to Sterility Concerns

    Pharm D Solutions is recalling Arginine Injections 100 mcg/mL due to a lack of assurance of sterility. The affected lots were distributed nationwide.

    Product
    Arginine Injections 100 mcg/mL, Pharm D Solutions, Houston, Texas NDC 69699-1414-20
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0214-2019·2018-11-07

    Pharm D Solutions Recalls Testosterone Cypionate/Proprinate Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling specific lots of Testosterone Cypionate/Proprinate 200 mg/10 mg/1 mL 30 mL Injectable because of a lack of assurance of sterility.

    Product
    Testosterone Cypionate/Proprinate 200 mg/10 mg/1 mL 30 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1745-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0152-2019·2018-11-07

    Pharm D Solutions Recalls Epinephrine Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling 945 syringes of Epinephrine 1 mg/1 mL injectable solution nationwide due to a lack of assurance of sterility.

    Product
    Epinepherine 1 mg/1 mL 3 mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-0109-03
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0180-2019·2018-11-07

    Pharm D Solutions Recalls Sermorelin/GHRP-2 Powder Due to Sterility Concerns

    Pharm D Solutions is recalling 409 vials of Sermorelin/GHRP-2 powder because the company cannot ensure the product is sterile.

    Product
    Sermorelin/GHRP-2 6 mg/6 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1727-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0189-2019·2018-11-07

    Pharm D Solutions Recalls Tilarginine Acetate Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling Tilarginine Acetate 50 mg/mL injectable vials because the company cannot ensure the product is sterile.

    Product
    Tilarginine Acetate 50 mg/mL, 10 mL, Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1461-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0155-2019·2018-11-07

    Pharm D Solutions Recalls Glycerin Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling Glycerin 72% Injectable due to a lack of assurance of sterility. The product was distributed nationwide.

    Product
    Glycerin 72% (Lidocaine/Epi 2:1) Injectable, Pharm D Solutions, Houston, Texas ---- NDC 69699-1401-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0211-2019·2018-11-07

    Pharm D Solutions Recalls Water for Injection Bags Due to Sterility Concerns

    Pharm D Solutions is recalling 12 bags of Water Sterile for Injection due to a lack of assurance of sterility. The product was distributed nationwide.

    Product
    Water Sterile for Injection 250 mL IV Pharm D Solutions, Houston, Texas --- NDC 69699-1407-25
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0124-2019·2018-11-07

    Sprayology Recalls Acne Tonic Homeopathic Oral Spray Due to CGMP Deviations

    Sprayology is recalling 919 bottles of Acne Tonic Homeopathic Oral Spray because manufacturing conditions could result in possible microbial contamination.

    Product
    Acne Tonic Homeopathic Oral Spray 1.38 fl. oz. (41 mL). Manufactured by Sprayology Gaithersburg, MD 20879. NDC 61096-0027-1
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0127-2019·2018-11-07

    Aurobindo Recalls Irbesartan Bulk Ingredient Due to Carcinogen Impurity

    Aurobindo Pharma is recalling Irbesartan bulk active ingredient because N-Nitrosodimethylamine (NDEA), a carcinogen, was detected. The product was distributed to one customer in New York.

    Product
    Irbesartan Bulk Active Pharmaceutical Ingredient.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0200-2019·2018-11-07

    Pharm D Solutions Recalls Trimix Injection Due to Sterility Concerns

    Pharm D Solutions is recalling 815 vials of Trimix injection because the company cannot guarantee the product is sterile.

    Product
    Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/20 mcg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1366-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0170-2019·2018-11-07

    Pharm D Solutions Recalls Phenol Injection Due to Sterility Concerns

    Pharm D Solutions is recalling Phenol 5% and Glycerin Aqueous Solution 10 mL Injection due to a lack of assurance of sterility.

    Product
    Phenol 5% and Glycerin Aqueous Solution 10 mL Injection, Pharm D Solutions, Houston, Texas --- NDC 69699-1431-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0145-2019·2018-11-07

    Pharm D Solutions Recalls Caffeine and Sodium Benzoate Injection Due to Sterility Concerns

    Pharm D Solutions is recalling Caffeine and Sodium Benzoate Injection 125 mg/125 mg/mL due to a lack of assurance of sterility. The recall covers 567 milliliters distributed nationwide.

    Product
    Caffeine and Sodium Benzoate Injection 125 mg/125 mg/mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-1428-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0147-2019·2018-11-07

    Pharm D Solutions Recalls Calcium Gluconate Eyewash Due to Sterility Concerns

    Pharm D Solutions is recalling 29 bottles of Calcium Gluconate 1% Eyewash because the company cannot ensure the product is sterile.

    Product
    Calcium Gluconate1% Eyewash 10 mg/mL, 125 mL bottles, Pharm D Solutions, Houston, Texas ---- NDC 69699-0906-12
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0212-2019·2018-11-07

    Pharm D Solutions Recalls Zinc Sulfate Injectable Due to Sterility Concerns

    Pharm 184 vials of Zinc Sulfate 1 mg/mL MDV Injectable are being recalled nationwide due to a lack of assurance of sterility.

    Product
    Zinc Sulfate 1 mg/mL MDV Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1418-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0183-2019·2018-11-07

    Pharm D Solutions Recalls Sermorelin Powder Due to Sterility Concerns

    Pharm D Solutions is recalling Sermorelin/GHRP-2 powder because the company cannot ensure the product is sterile.

    Product
    Sermorelin/GHRP-2 9 mg/9 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1715-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0156-2019·2018-11-07

    Pharm D Solutions Recalls HCG Lyophilized Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling 2,219 vials of HCG Lyophilized 5000 IU Injectable because the product lacks assurance of sterility.

    Product
    HCG Lyophilized 5000 IU Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-1707-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0190-2019·2018-11-07

    Pharm D Solutions Recalls Tri-Mix XL Injectable Due to Sterility Concerns

    Pharm D Solutions is recalling 553 vials of Tri-Mix XL injectable and powder nationwide due to a lack of assurance of sterility.

    Product
    Tri-Mix XL 150 mg/10 mg/100 mcg a) Injectable NDC 69699-1353-10; b) (LYO) Powder NDC 69699-1353-10, Pharm D Solutions, Houston, Texas
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0111-2019·2018-11-07

    Sprayology Recalls AllergEase Homeopathic Oral Spray Due to CGMP Deviations

    Sprayology is recalling 4,153 bottles of AllergEase Homeopathic Oral Spray because manufacturing conditions could result in possible microbial contamination.

    Product
    AllergEase, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0003-1
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0107-2019·2018-11-07

    Sprayology Recalls Brain Power Homeopathic Oral Spray Due to CGMP Deviations

    Sprayology is recalling Brain Power Homeopathic Oral Spray because it was manufactured under conditions that could result in possible microbial contamination.

    Product
    Brain Power,Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0033-1
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0113-2019·2018-11-07

    Sprayology Recalls DigestivEase Homeopathic Oral Spray Due to CGMP Deviations

    Sprayology is recalling 1,465 bottles of DigestivEase Homeopathic Oral Spray due to manufacturing conditions that could result in microbial contamination.

    Product
    DigestivEase, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879.NDC 61096-0005-1
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0122-2019·2018-11-07

    Sprayology Recalls ImmunoBooster Homeopathic Oral Spray Due to CGMP Deviations

    Sprayology is recalling 2,837 bottles of ImmunoBooster Homeopathic Oral Spray nationwide due to manufacturing conditions that could result in microbial contamination.

    Product
    ImmunoBooster, Homeopathic Oral Spray 1.38 fl. oz. (41 mL). Manufactured by Sprayology Gaithersburg, MD 20879. NDC 61096-0038-1
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0106-2019·2018-11-07

    Sprayology Recalls Man Power Homeopathic Oral Spray Due to CGMP Deviations

    Sprayology is recalling Man Power Homeopathic Oral Spray because it was manufactured under conditions that could result in possible microbial contamination.

    Product
    Man Power, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0025-1 and Tester NDC 61096-1025-1
    Category
    Drug
    Distribution
    Distributed nationwide